Polypharmacy status as an indicator of mortality in an elderly population - PubMed (original) (raw)
Comparative Study
Polypharmacy status as an indicator of mortality in an elderly population
Johanna Jyrkkä et al. Drugs Aging. 2009.
Abstract
Background: Increased use of drugs has raised concern about the risks of polypharmacy in elderly populations. Adverse outcomes, such as hospitalizations and falls, have been shown to be associated with polypharmacy. So far, little information is available on the association between polypharmacy status and mortality.
Objective: To assess whether polypharmacy (six to nine drugs) or excessive polypharmacy (ten or more drugs) could be indicators of mortality in elderly persons.
Methods: This was a population-based cohort study conducted between 1998 and 2003 with mortality follow-up through to 2007. The data in this study were derived from the population-based Kuopio 75+ Study, which involved elderly persons aged>or=75 years living in the city of Kuopio, Finland. The initial sample (sample frame n=4518, random sample n=700) was drawn from the population register. For the purpose of this study, two separate analyses were carried out. In the first phase, participants (aged>or=75 years, n=601) were followed from 1998 (baseline) to 2002. In the second phase, survivors (aged>or=80 years, n=339) were followed from 2003 to 2007. Current medications were determined from drug containers and prescriptions during interviews conducted by a trained nurse. The Kaplan-Meier method and Cox proportional hazards regression were used to examine the association between polypharmacy status and mortality.
Results: In the first phase, 28% (n=167) belonged to the excessive polypharmacy group, 33% (n=200) to the polypharmacy group, and the remaining 39% (n=234) to the non-polypharmacy (0-5 drugs) group. The corresponding figures in the second phase were 28% (n=95), 39% (n=132) and 33% (n=112), respectively. The mortality rate was 37% in the first phase and 40% in the second phase. In both phases, the survival curves showed a significant difference in all-cause mortality between the three polypharmacy groups. In the first phase, the univariate model showed an association between excessive polypharmacy and mortality (hazard ratio [HR] 2.53, 95% CI 1.83, 3.48); however, after adjustment for demographics and other variables measuring functional and cognitive status, this association did not remain statistically significant (HR 1.28, 95% CI 0.86, 1.91). In the second phase, the association between excessive polypharmacy and mortality (HR 2.23, 95% CI 1.21, 4.12) remained significant after adjustments. Age, male sex and dependency according to the Instrumental Activities of Daily Living screening instrument were associated with mortality in both phases.
Conclusion: This study points to the importance of excessive polypharmacy as an indicator for mortality in elderly persons. This association needs to be confirmed following adjustment for co-morbidities.
Similar articles
- Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis.
Jyrkkä J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Jyrkkä J, et al. Drugs Aging. 2009;26(6):493-503. doi: 10.2165/00002512-200926060-00006. Drugs Aging. 2009. PMID: 19591524 - Polypharmacy in the Elderly: A Marker of Increased Risk of Mortality in a Population-Based Prospective Study (NEDICES).
Gómez C, Vega-Quiroga S, Bermejo-Pareja F, Medrano MJ, Louis ED, Benito-León J. Gómez C, et al. Gerontology. 2015;61(4):301-9. doi: 10.1159/000365328. Epub 2014 Dec 6. Gerontology. 2015. PMID: 25502492 - Survival of the elderly and exposition to polypharmacy in the city of São Paulo, Brazil: SABE Study.
Romano-Lieber NS, Corona LP, Marques LFG, Secoli SR. Romano-Lieber NS, et al. Rev Bras Epidemiol. 2019 Feb 4;21Suppl 02(Suppl 02):e180006. doi: 10.1590/1980-549720180006.supl.2. Rev Bras Epidemiol. 2019. PMID: 30726351 English, Portuguese. - Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+Study.
Jyrkkä J, Vartiainen L, Hartikainen S, Sulkava R, Enlund H. Jyrkkä J, et al. Eur J Clin Pharmacol. 2006 Feb;62(2):151-8. doi: 10.1007/s00228-005-0079-6. Epub 2006 Jan 12. Eur J Clin Pharmacol. 2006. PMID: 16408226 - Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people.
Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Herr M, et al. Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):637-46. doi: 10.1002/pds.3772. Epub 2015 Apr 8. Pharmacoepidemiol Drug Saf. 2015. PMID: 25858336
Cited by
- Antiseizure Medication Withdrawal, Risk of Epilepsy, and Longterm EEG Trends in Acute Symptomatic Seizures or Epileptic EEG Patterns.
Sivaraju A, Tao A, Jadav R, Kirunda KN, Rampal N, Kim JA, Gilmore EJ, Hirsch LJ. Sivaraju A, et al. Neurol Clin Pract. 2024 Dec;14(6):e200342. doi: 10.1212/CPJ.0000000000200342. Epub 2024 Aug 16. Neurol Clin Pract. 2024. PMID: 39185097 - Prehospital point-of-care medication burden as a predictor of poor related outcomes in unselected acute diseases.
Jurado-Palomo J, Sanz-García A, Martín-Conty JL, Polonio-López B, López-Izquierdo R, Sáez-Belloso S, Del Pozo Vegas C, Martín-Rodríguez F. Jurado-Palomo J, et al. Intern Emerg Med. 2024 Aug 2. doi: 10.1007/s11739-024-03729-x. Online ahead of print. Intern Emerg Med. 2024. PMID: 39090370 - Prevalence, country-specific prescribing patterns and determinants of benzodiazepine use in community-residing older adults in 7 European countries.
Lukačišinová A, Reissigová J, Ortner-Hadžiabdić M, Brkic J, Okuyan B, Volmer D, Tadić I, Modamio P, Mariño EL, Tachkov K, Liperotti R, Onder G, Finne-Soveri H, van Hout H, Howard EP, Fialová D. Lukačišinová A, et al. BMC Geriatr. 2024 Mar 7;24(1):240. doi: 10.1186/s12877-024-04742-7. BMC Geriatr. 2024. PMID: 38454372 Free PMC article. - Evaluation of deprescription by general practitioners in elderly people with different levels of dependence: cross-sectional study.
Coelho T, Rosendo I, Seiça Cardoso C. Coelho T, et al. BMC Prim Care. 2024 Mar 2;25(1):78. doi: 10.1186/s12875-024-02299-3. BMC Prim Care. 2024. PMID: 38431577 Free PMC article. - Characteristics and Attendance of Patients Eligible for the PASS Clinic: A Transition of Care Model After Acute Symptomatic Seizures.
Byrnes M, Thompson NR, Hantus ST, Fesler JR, Ying Z, Ayub N, Rubinos C, Zafar S, Sivaraju A; as the Post-Acute Symptomatic Seizure Investigation and Outcomes Network (PASSION) investigators; Punia V. Byrnes M, et al. Neurol Clin Pract. 2024 Feb;14(1):e200232. doi: 10.1212/CPJ.0000000000200232. Epub 2024 Jan 5. Neurol Clin Pract. 2024. PMID: 38213398
References
- BMC Geriatr. 2008 Dec 22;8:34 - PubMed
- J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
- J Am Geriatr Soc. 2006 Apr;54(4):598-605 - PubMed
- Age Ageing. 2005 Nov;34(6):626-32 - PubMed
- Fam Pract. 2000 Jun;17(3):261-7 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources